
Novo Nordisk's stock is taking a hit Tuesday morning after Easter brought good news to arch-rival Eli Lilly. (Archive photo). Photo: Mads Claus Rasmussen/Ritzau Scanpix
Novo shares plunge after news on rival weight-loss drug
On Tuesday, Danish Novo Nordisk’s stock price fell by 6.9% following good news over Easter for its American competitor, Eli Lilly. Both companies are competing in the weight loss drug market. Eli Lilly announced that its new weight loss pill, orforglipron, successfully passed a phase 3 study,...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?